Trulicity (dulaglutide) is a once-weekly GLP-1 receptor agonist approved for type 2 diabetes management. This evidence-b...
Empagliflozin has reshaped type 2 diabetes management. Here is the complete clinical breakdown — from HbA1c reduction an...
Once reserved as third-line agents, GLP-1 receptor agonists are now central to type 2 diabetes management. This in-depth...
Type 2 diabetes often develops without obvious symptoms. Learn to recognize the quiet, early warning signals that can he...
Recognizing the subtle and urgent signs of type 1 and type 2 diabetes in children can prevent life-threatening complicat...
Early detection remains the single most powerful tool against the type 2 diabetes epidemic. In 2026, the American Diabet...
The fasting blood sugar test is often the first — and most accessible — tool clinicians use to screen for diabetes. But ...
More than 37 million Americans have diabetes, and nearly 1 in 3 adults have prediabetes — yet most cannot interpret thei...
More than 1 in 3 adults in the United States has prediabetes, yet over 80% of them are unaware of their condition. Under...
Up to 50% of people with diabetes develop neuropathy. Learn how to spot the earliest signs — from numbness and burning t...
Recognizing the subtle and overt signs of DKA can mean the difference between a manageable metabolic crisis and a life-t...
Millions of adults are living with undiagnosed type 2 diabetes or prediabetes. Early metabolic red flags are often subtl...